🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareCost-effectiveness analysis: GLP-1 agonists vs bariatric surgery (ICER 2026) — March 2026 Page 3

Cost-effectiveness analysis: GLP-1 agonists vs bariatric surgery (ICER 2026) — March 2026

Dr.EndoEP Mon, Dec 11, 2023 at 5:14 PM 15 replies 2,066 viewsPage 3 of 3
DerekSJ_a1c
Member
378
1,678
Aug 2024
San Jose, CA
Dec 11, 2023 at 9:29 PM#11

Subscribing to this thread. Cost-effectiveness is exactly what I've been researching. 🙏

8 9adam_van, Dr.SurgeonPGH, rachel_ABQ and 5 others
Reply Quote Save Share Report
nancy_portland
Member
345
1,567
Aug 2024
Portland, ME
Dec 11, 2023 at 9:46 PM#12

Reading this thread on Cost-effectiveness hits close to home. Dad of 2 checking in — I started at 269 lbs and felt like I would tried everything.

15 months on tirz and I am a different person. Not just the 44 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Cost-effectiveness — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Dec 11, 2023 at 10:46 PM
44 23KristenIndy, MarkLI_maint, Dr.PeteFamMed and 41 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Dec 11, 2023 at 10:03 PM#13

Moderator note: Great discussion, everyone. Just a reminder to keep things civil and evidence-based.

Thread quality is excellent — keep it up. 👍

37 22RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 34 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Dec 11, 2023 at 10:20 PM#14

Relevant to Cost-effectiveness analysis — here is my latest bloodwork comparison:

Key improvements: A1C 8.4% → 5.5%, triglycerides 201 → 101 mg/dL, hsCRP 8.0 → 1.3 mg/L. All on tirzepatide for 17 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Last edited: Dec 11, 2023 at 11:20 PM
2 10hans_munich, jason_sac26
Reply Quote Save Share Report
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
Dec 11, 2023 at 10:37 PM#15

Congrats DerekSJ_a1c!! You should be so proud of yourself. 🎉 👏

5 15pete_manc_UK, anna.melb_AU, mark_tokyo and 2 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register